首页> 外文期刊>Cancer letters >Detection of R337H, a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern Brazil.
【24h】

Detection of R337H, a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern Brazil.

机译:在巴西南部参加乳腺癌筛查计划的无症状妇女中检测到R337H,这是一种易患多种癌症的TP53突变种。

获取原文
获取原文并翻译 | 示例
           

摘要

Germline TP53 mutations predispose to a rare familial cancer syndrome, the Li-Fraumeni Syndrome (LFS), characterized by the early onset of multiple cancers including childhood adrenocortical carcinomas, sarcomas and brain tumors, and breast and colon cancer in young adults. An identical germline mutation at codon 337 in TP53 (R337H) has been shown to be causally related to an increased risk of multiple cancers in unrelated subjects with familial cancer risk in Southern Brazil. Here we have assessed the prevalence of R337H in 750 healthy women participating in a community-based breast cancer screening program in the area of Porto Alegre. The mutant was detected in two participants (0.3%) who were fourth-degree relatives and reported a familial history of cancer at multiple sites that did not match classical criteria for LFS and its variants. Testing in additional family members detected the mutation in three subjects, one of whom developed breast cancer at the age of 36. These findings indicate that R337H may be a low penetrance mutant which predisposes to multiple cancers and occurs in the population of Southern Brazil at a frequency 10-20 times higher than other TP53 mutants commonly associated with LFS.
机译:胚系TP53突变是一种罕见的家族性癌症综合症,即Li-Fraumeni综合征(LFS),其特征是多种癌症的早期发作,包括儿童时期的肾上腺皮质癌,肉瘤和脑瘤,以及年轻人的乳腺癌和结肠癌。 TP53(R337H)中第337位密码子的相同种系突变已显示与巴西南部具有家族性癌症风险的无关受试者发生多种癌症的风险增加有因果关系。在这里,我们评估了在阿雷格里港地区参加基于社区的乳腺癌筛查计划的750名健康女性中R337H的患病率。在四级亲属的两名参与者中检测到该突变体(0.3%),并报告了多个地点的家族癌症史,这些地点与LFS及其变体的经典标准不符。在其他家庭成员中进行的测试检测了三名受试者的突变,其中一位在36岁时患了乳腺癌。这些发现表明R337H可能是一种低渗透力突变体,易患多种癌症,并发生在巴西南部的人群中。频率比通常与LFS相关的其他TP53突变体高10-20倍。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号